| pubmed-article:11304763 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11304763 | lifeskim:mentions | umls-concept:C0684249 | lld:lifeskim |
| pubmed-article:11304763 | lifeskim:mentions | umls-concept:C1512162 | lld:lifeskim |
| pubmed-article:11304763 | lifeskim:mentions | umls-concept:C0008838 | lld:lifeskim |
| pubmed-article:11304763 | lifeskim:mentions | umls-concept:C0015133 | lld:lifeskim |
| pubmed-article:11304763 | lifeskim:mentions | umls-concept:C0146224 | lld:lifeskim |
| pubmed-article:11304763 | lifeskim:mentions | umls-concept:C0302523 | lld:lifeskim |
| pubmed-article:11304763 | lifeskim:mentions | umls-concept:C0700325 | lld:lifeskim |
| pubmed-article:11304763 | lifeskim:mentions | umls-concept:C0282461 | lld:lifeskim |
| pubmed-article:11304763 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:11304763 | pubmed:dateCreated | 2001-4-17 | lld:pubmed |
| pubmed-article:11304763 | pubmed:abstractText | To determine the efficacy of topotecan in combination with standard chemotherapy in previously untreated patients with extensive-stage small-cell lung cancer (SCLC), the Eastern Cooperative Oncology Group (ECOG) conducted a phase III trial. | lld:pubmed |
| pubmed-article:11304763 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11304763 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11304763 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11304763 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11304763 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11304763 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11304763 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11304763 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11304763 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11304763 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11304763 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11304763 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11304763 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:11304763 | pubmed:issn | 0732-183X | lld:pubmed |
| pubmed-article:11304763 | pubmed:author | pubmed-author:JohnsonD HDH | lld:pubmed |
| pubmed-article:11304763 | pubmed:author | pubmed-author:SchillerJ HJH | lld:pubmed |
| pubmed-article:11304763 | pubmed:author | pubmed-author:CellaDD | lld:pubmed |
| pubmed-article:11304763 | pubmed:author | pubmed-author:AdanNN | lld:pubmed |
| pubmed-article:11304763 | pubmed:author | pubmed-author:DeVoreR... | lld:pubmed |
| pubmed-article:11304763 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11304763 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:11304763 | pubmed:volume | 19 | lld:pubmed |
| pubmed-article:11304763 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11304763 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11304763 | pubmed:pagination | 2114-22 | lld:pubmed |
| pubmed-article:11304763 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:11304763 | pubmed:meshHeading | pubmed-meshheading:11304763... | lld:pubmed |
| pubmed-article:11304763 | pubmed:meshHeading | pubmed-meshheading:11304763... | lld:pubmed |
| pubmed-article:11304763 | pubmed:meshHeading | pubmed-meshheading:11304763... | lld:pubmed |
| pubmed-article:11304763 | pubmed:meshHeading | pubmed-meshheading:11304763... | lld:pubmed |
| pubmed-article:11304763 | pubmed:meshHeading | pubmed-meshheading:11304763... | lld:pubmed |
| pubmed-article:11304763 | pubmed:meshHeading | pubmed-meshheading:11304763... | lld:pubmed |
| pubmed-article:11304763 | pubmed:meshHeading | pubmed-meshheading:11304763... | lld:pubmed |
| pubmed-article:11304763 | pubmed:meshHeading | pubmed-meshheading:11304763... | lld:pubmed |
| pubmed-article:11304763 | pubmed:meshHeading | pubmed-meshheading:11304763... | lld:pubmed |
| pubmed-article:11304763 | pubmed:meshHeading | pubmed-meshheading:11304763... | lld:pubmed |
| pubmed-article:11304763 | pubmed:meshHeading | pubmed-meshheading:11304763... | lld:pubmed |
| pubmed-article:11304763 | pubmed:meshHeading | pubmed-meshheading:11304763... | lld:pubmed |
| pubmed-article:11304763 | pubmed:meshHeading | pubmed-meshheading:11304763... | lld:pubmed |
| pubmed-article:11304763 | pubmed:meshHeading | pubmed-meshheading:11304763... | lld:pubmed |
| pubmed-article:11304763 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11304763 | pubmed:articleTitle | Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer: E7593--a phase III trial of the Eastern Cooperative Oncology Group. | lld:pubmed |
| pubmed-article:11304763 | pubmed:affiliation | University of Wisconsin Hospital and Clinics, Madison, WI 53792, USA. jhschill@facstaff.wisc.edu | lld:pubmed |
| pubmed-article:11304763 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11304763 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:11304763 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:11304763 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
| pubmed-article:11304763 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:11304763 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| pubmed-article:11304763 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11304763 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11304763 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11304763 | lld:pubmed |
